VISN 15 A1C cprr testing to fund the exercise of option period 3

Ended Awarded Last action

Contract number
36C25523N0222
Awardee
Awarding agency
Obligated
$273,000

Award facts

Contract value 100% obligated
$272,999.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00006 -$7,982
Supplemental Agreement for work within scope P00005 · VISN 15 A1C cprr testing MOD to option period 3 to DE-obligate funds not used due to lower patient need than originally estimated. -$36,367
Supplemental Agreement for work within scope P00004 · VISN 15 A1C cprr testing MOD to option period 3 to increase funds so the topeka station as there were more patients than originally estimated that need tests. $1,876
Supplemental Agreement for work within scope P00003 · VISN 15 A1C cprr testing MOD to option period 3 to increase funds so the wichita station as there were more patients than originally estimated that need tests. $539
Supplemental Agreement for work within scope P00002 · VISN 15 A1C cprr testing MOD to option period 3 to increase funds so the columbia station can order more supplies as there were more patience than originally… $6,500
Supplemental Agreement for work within scope P00001 · VISN 15 A1C cprr testing MOD to option period 3 to increase funds so the station can order more supplies as there were more patience than originally estimated… $3,906
Original award $304,528

About this award

The U.S. Department of Veterans Affairs (VA) has awarded a $272,999.80 firm fixed-price Blanket Purchase Agreement (BPA) call order to Tosoh Bioscience, Inc., doing business as Tosoh USA, to fund the exercise of Option Period 3 for VISN 15 Hemoglobin A1C (HbA1c) CPRR Testing. This contract, issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, provides the VA's Veterans Integrated Service Network 15 with specialized HbA1c testing equipment, reagents, and related clinical diagnostic supplies to support diabetes management for veteran patients. Tosoh Bioscience is an experienced provider of HPLC-based HbA1c testing solutions to federal healthcare networks, having previously secured multiple BPA contracts with the VA to deliver these services across its integrated health networks. This award does not utilize any small business set-aside designations.

Quick answers

Who was awarded contract 36C25523N0222?

36C25523N0222 was awarded to Tosoh Bioscience, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2023.

How much is contract 36C25523N0222 worth?

The government has obligated $273,000 on 36C25523N0222.

Is contract 36C25523N0222 an order under another contract?

Yes. 36C25523N0222 is a BPA call under V797D40130-36C25520A0026, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C25523N0222 competed?

The extent of competition for 36C25523N0222 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award